C57BL/6JGpt-B3galnt1em3Cd5671/Gpt

Mouse Model: B3galnt1-KO
Strain Number: T033190

Knockout (KO)

  • Product Type:
  • Quantity: - +
  • Sex:
  • Age:
  • Genotype:

GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library

With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.

BASIC INFORMATION
Strain Name: C57BL/6JGpt-B3galnt1em3Cd5671/Gpt
Strain Number: T033190
Official Symbol: B3galnt1
Strain Strategy: T033190.B3galnt1 Cas9-KO Strategy-EN.pdf
Official Full Name: UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1
Also Known As: B3galt3,b3GT3
NCBI Number: 26879
MGI Number: 1349405
Chromosome: 3
Deletion (size): -5671bp
Research Areas: Metabolic research,Developmental Biology,reproductive system,Protein metabolism,Glucose metabolism,Physiological system,Cell biology,Molecular biology,mortality/aging,endoplasmic reticulum,Golgi apparatus,transferase
Strain Background: [N000013] C57BL/6JGpt
Modification Type: Knockout (KO)
Genotyping Protocols: T033190.B3galnt1 Genotyping Protocol(KO).pdf
Inventory Status: Cryopreserved
Sale Status: IF (Available for Distribution)
Health Status: Specific pathogen free (SPF)
Health Report: Please log in to view
Gene Family: Beta 3-glycosyltransferasesBlood group antigens

Extend the Value of Your Mouse Models with Integrated Preclinical Services

GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.